Aptose Biosciences Stock Current Ratio
| APTO Stock | USD 0.19 0.05 20.83% |
Aptose Biosciences fundamentals help investors to digest information that contributes to Aptose Biosciences' financial success or failures. It also enables traders to predict the movement of Aptose Stock. The fundamental analysis module provides a way to measure Aptose Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aptose Biosciences stock.
| Last Reported | Projected for Next Year | ||
| Current Ratio | 0.78 | 0.74 |
Aptose | Current Ratio |
Aptose Biosciences Company Current Ratio Analysis
Aptose Biosciences' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Aptose Biosciences Current Ratio | 6.89 X |
Most of Aptose Biosciences' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aptose Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Aptose Current Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Aptose Biosciences is extremely important. It helps to project a fair market value of Aptose Stock properly, considering its historical fundamentals such as Current Ratio. Since Aptose Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aptose Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aptose Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Aptose Current Ratio Historical Pattern
Today, most investors in Aptose Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Aptose Biosciences' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current ratio growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Aptose Biosciences current ratio as a starting point in their analysis.
Aptose Biosciences Current Ratio |
| Timeline |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Aptose Biosciences has a Current Ratio of 6.89 times. This is 136.77% higher than that of the Biotechnology sector and about the same as Health Care (which currently averages 7.0) industry. The current ratio for all United States stocks is notably lower than that of the firm.
Aptose Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aptose Biosciences' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aptose Biosciences could also be used in its relative valuation, which is a method of valuing Aptose Biosciences by comparing valuation metrics of similar companies.Aptose Biosciences is currently under evaluation in current ratio category among its peers.
Aptose Biosciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Aptose Biosciences from analyzing Aptose Biosciences' financial statements. These drivers represent accounts that assess Aptose Biosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Aptose Biosciences' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 19.0M | 23.9M | 8.0M | 3.6M | 3.2M | 4.6M | |
| Enterprise Value | (59.3M) | (92.4M) | (30.5M) | (32.1M) | (36.9M) | (35.1M) |
Aptose Fundamentals
| Return On Equity | -6.94 | ||||
| Return On Asset | -1.36 | ||||
| Current Valuation | (2.76 M) | ||||
| Shares Outstanding | 19.52 M | ||||
| Shares Owned By Insiders | 15.87 % | ||||
| Shares Owned By Institutions | 16.68 % | ||||
| Number Of Shares Shorted | 123.22 K | ||||
| Price To Earning | (1.80) X | ||||
| Price To Book | 67.84 X | ||||
| EBITDA | (52.27 M) | ||||
| Net Income | (51.21 M) | ||||
| Cash And Equivalents | 62.41 M | ||||
| Cash Per Share | 0.68 X | ||||
| Total Debt | 1.01 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 6.89 X | ||||
| Book Value Per Share | (0.36) X | ||||
| Cash Flow From Operations | (44.59 M) | ||||
| Short Ratio | 1.82 X | ||||
| Earnings Per Share | (2.92) X | ||||
| Target Price | 2.0 | ||||
| Number Of Employees | 35 | ||||
| Beta | 1.36 | ||||
| Market Capitalization | 4.76 M | ||||
| Total Asset | 12.99 M | ||||
| Retained Earnings | (515.54 M) | ||||
| Working Capital | (3.38 M) | ||||
| Current Asset | 14.98 M | ||||
| Current Liabilities | 1.7 M | ||||
| Net Asset | 12.99 M |
About Aptose Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aptose Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aptose Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aptose Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aptose Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptose Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving against Aptose Stock
The ability to find closely correlated positions to Aptose Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptose Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptose Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptose Biosciences to buy it.
The correlation of Aptose Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptose Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptose Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptose Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Aptose Biosciences Piotroski F Score and Aptose Biosciences Altman Z Score analysis. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptose Biosciences. If investors know Aptose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptose Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.92) | Return On Assets (1.36) | Return On Equity (6.94) |
The market value of Aptose Biosciences is measured differently than its book value, which is the value of Aptose that is recorded on the company's balance sheet. Investors also form their own opinion of Aptose Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Aptose Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptose Biosciences' market value can be influenced by many factors that don't directly affect Aptose Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptose Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptose Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptose Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.